Institute for Computational Medicine
Institute for Computational Medicine
Prostate cancer is heterogeneous: it is a hodgepodge of different kinds of cells, some worse than others. This often means the cancer becomes resistant to therapy – but sometimes, this change opens a new avenue of treatment that wasn’t there before. In a recent...
Prof. Rachel Karchin and lead software engineer Kyle Moad lead a workshop and discussion about increasing the transparency of variant effect prediction at the Cancer Genomics Consortium Unconference, August 3, 2024 in St. Louis, Missouri. Read more here:...
Dr. Sri Sarma, core faculty member of ICM, associate professor of Biomedical Engineering, and Vice Dean for graduate education and lifelong learning, has been selected to receive an NIH Outstanding Investigator Award meant to help investigators make meaningful...